Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial) [COHORT]
- To examine if common and potentially modifiable dietary, lifestyle, and environmental
exposures affect the risk of recurrence and progression in bladder cancer.
OUTLINE: This is a multicenter study.
Detailed information will be collected about the patients' lifestyle and their exposure to
risk factors associated with bladder cancer using semi-structured questionnaires. A baseline
questionnaire will be administered at the time of diagnosis and will collect information
about socio-demographics, environmental exposures, medical history, diet, health-related
quality of life, and social support.
Further questionnaires will be administered at regular follow-up visits to capture
information relating to changes in exposure. A postal questionnaire will be used to collect
historical information that may require the patient to check records or consult family or
friends. Patients will also be asked to keep a 1-week food, fluid, and micturition diary.
Patients continue to complete questionnaires at 3 months and then annually for up to 5
Peer Reviewed and Funded or Endorsed by Cancer Research UK.
Recurrence at 5 years
University of Birmingham